Home

Schizophrenia

Read time: 3 min

Satellite symposium

Understanding patient preferences to increase treatment adherence in schizophrenia

Schizophrenia is a debilitating and lifelong mental health disorder characterized by disorganized...

Read time: 4 min

Satellite symposium

The importance of patient life engagement in schizophrenia

At the 2023 ECNP Congress in Barcelona, Spain (7−10th Oct), two symposia explored the...

Early schizophrenia intervention positively benefits functionality and reduces number of lifetime relapses

Professor Leslie Citrome sat down at ECNP 2022 to discuss how early intervention is critical for...

Taking the long-term view of schizophrenia treatment from first diagnosis

Professor Christoph Correll discussed at ECNP the need for a holistic, long-term view of...

Read time: 5 min

Congress highlights

Exploring the relationship between cannabis use and psychosis

Epidemiological evidence demonstrates an association between the use of cannabis and increased risk...

Bipolar, Schizophrenia

Read time: 5 min

Satellite symposium

Expanding Therapeutic Options and Developing Novel Long-Acting Injectables in Schizophrenia

The 2023 Schizophrenia International Research Society (SIRS) symposium opened on May 11, 2023 with...

Read time: 3 min

Congress highlights

Glutamate and Oxidative Stress: A novel approach to pathophysiology in schizophrenia

It is well accepted that a combination of genetic and environmental factors is implicated in the...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country